In silico molecular modeling and docking studies on the Leishmania mitochondrial iron transporter-1 (LMIT1)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, Boer M, the WHO Leishmaniasis Control Team (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7:e35671
Benkert P, Tosatto SC, Schomburg D (2008) QMEAN: a comprehensive scoring function for model quality assessment. Proteins: Struct, Funct Bioinf 71:261–277
Benkert P, Biasini M, Schwede T (2010) Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 27:343–350
Bezerra IPS, Abib MA, Rossi-Bergmann B (2018) Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis. Vaccine 36:2480–2486
Bhattacharya D, Cheng J (2013) i3Drefine software for protein 3D structure refinement and its assessment in CASP10. PLoS One 8:e69648
Brezovsky J, Chovancova E, Gora A, Pavelka A, Biedermannova L, Damborsky J (2013) Software tools for identification, visualization and analysis of protein tunnels and channels. Biotechnol Adv 31:38–49
Carugo O, Djinović-Carugo K (2013) Half a century of Ramachandran plots. Acta Crystallogr Sect D 69:1333–1341
Das BB, Sengupta T, Ganguly A, Majumder HK (2006) Topoisomerases of kinetoplastid parasites: why so fascinating? Mol Microbiol 62:917–927
dos Santos IB et al (2018) Leishmanicidal and immunomodulatory activities of the Palladacycle complex DPPE 1.1, a potential candidate for treatment of cutaneous Leishmaniasis. Front Microbiol 9:1–9
Fidalgo LM, Gille L (2011) Mitochondria and trypanosomatids: targets and drugs. Pharm Res 28:2758–2770
Floudas C, Fung H, McAllister S, Mönnigmann M, Rajgaria R (2006) Advances in protein structure prediction and de novo protein design: a review. Chem Eng Sci 61:966–988
Geourjon C, Deleage G (1995) SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Bioinformatics 11:681–684
Hajilooi M, Sardarian K, Dadmanesh M, Matini M, Lotfi P, Bazmani A, Tabatabaiefar MA, Arababadi MK, Momeni M (2013) Is the IL-10− 819 polymorphism associated with visceral Leishmaniasis? Inflammation 36:1513–1518
Kar S, Roy K (2013) How far can virtual screening take us in drug discovery? Expert Opin Drug Discov 8:245–261
Keyvani H, Ahmadi NA, Ranjbar MM, Kachooei SA, Ghorban K, Dadmanesh M (2016) Immunoinformatics study of gp120 of human immunodeficiency virus type 1 subtype CRF35_AD isolated from Iranian patients. Arch Clin Infect Dis 11:1–9
Khalili S, Rahbar MR, Dezfulian MH, Jahangiri A (2015) In silico analyses of Wilms′ tumor protein to designing a novel multi-epitope DNA vaccine against cancer. J Theor Biol 379:66–78
Khalili S, Mohammadpour H, BAROUGH MS, Kokhaei P (2016) ILP-2 modeling and virtual screening of an FDA-approved library: a possible anticancer therapy. Turk J Med Sci 46:1135–1143
Khalili S, Jahangiri A, Hashemi ZS, Khalesi B, Mard-Soltani M, Amani J (2017a) Structural pierce into molecular mechanism underlying Clostridium perfringens epsilon toxin function. Toxicon 127:90–99
Khalili S, Rasaee M, Bamdad T (2017b) 3D structure of DKK1 indicates its involvement in both canonical and non-canonical Wnt pathways. Mol Biol 51:155–166
Khalili S, Zakeri A, Hashemi ZS, Masoumikarimi M, Manesh MRR, Shariatifar N, Sani MJ (2017c) Structural analyses of the interactions between the thyme active ingredients and human serum albumin. Turk J Biochem 42:459–467
Kim DE, Chivian D, Baker D (2004) Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res 32:W526–W531
Kopp J, Schwede T (2004) Automated protein structure homology modeling: a progress report. Pharmacogenomics 5:405–416
Lacapere J-J, Pebay-Peyroula E, Neumann J-M, Etchebest C (2007) Determining membrane protein structures: still a challenge! Trends Biochem Sci 32:259–270
Liang J, Naveed H, Jimenez-Morales D, Adamian L, Lin M (2012) Computational studies of membrane proteins: models and predictions for biological understanding. Biochim Biophys Acta Biomembr 1818:927–941
Lin H-N, Sung T-Y, Ho S-Y, Hsu W-L (2010) Improving protein secondary structure prediction based on short subsequences with local structure similarity. BMC Genomics 4:1–14
Magaraci F, Jimenez, Rodrigues C, Rodrigues JCF, Braga MV, Yardley V, de Luca-Fradley K, Croft SL, de Souza W, Ruiz-Perez LM, Urbina J, Pacanowska DG, Gilbert IH (2003) Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma c ruzi. J Med Chem 46:4714–4727
Martinez PA, Petersen CA (2014) Chronic infection by Leishmania amazonensis mediated through MAPK ERK mechanisms. Immunol Res 59:153–165
Martínez-García M et al (2016) LmABCB3, an atypical mitochondrial ABC transporter essential for Leishmania major virulence, acts in heme and cytosolic iron/sulfur clusters biogenesis. Parasit Vectors 9:1–17
Mather MW, Henry KW, Vaidya AB (2007) Mitochondrial drug targets in apicomplexan parasites. Curr Drug Targets 8:49–60
McGuffin LJ, Bryson K, Jones DT (2000) The PSIPRED protein structure prediction server. Bioinformatics 16:404–405
Mehta A, Shaha C (2004) Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition complex II inhibition results in increased Pentamidine cytotoxicity. J Biol Chem 279:11798–11813
Mittra B, Cortez M, Haydock A, Ramasamy G, Myler PJ, Andrews NW (2013) Iron uptake controls the generation of Leishmania infective forms through regulation of ROS levels. J Exp Med 210:401–416
Mittra B, Laranjeira-Silva MF, de Menezes JPB, Jensen J, Michailowsky V, Andrews NW (2016) A trypanosomatid iron transporter that regulates mitochondrial function is required for Leishmania amazonensis virulence. PLoS Pathog 12:e1005340
Mittra B, Laranjeira-Silva MF, Miguel DC, de Menezes JPB, Andrews NW (2017) The iron-dependent mitochondrial superoxide dismutase SODA promotes Leishmania virulence. J Biol Chem 21:1–32
Mohammadpour H, Khalili S, Hashemi ZS (2015) Kremen is beyond a subsidiary co-receptor of Wnt signaling: an in silico validation. Turk J Biol 39:501–510
Molegro A (2011) MVD 5.0 Molegro virtual Docker DK-8000 Aarhus C, Denmark
Monzote L, Gille L (2010) Mitochondria as a promising antiparasitic target. Curr Clin Pharmacol 5:55–66
Nagle AS, Khare S, Kumar AB, Supek F, Buchynskyy A, Mathison CJN, Chennamaneni NK, Pendem N, Buckner FS, Gelb MH, Molteni V (2014) Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis. Chem Rev 114:11305–11347
Niu Q, Li S, Chen D, Chen Q, Chen J (2016) Iron acquisition in Leishmania and its crucial role in infection. Parasitology 143:1347–1357
de Oliveira AM, Custódio FB, Donnici CL, Montanari CA (2003) QSAR and molecular modelling studies on B-DNA recognition of minor groove binders European. J Med Chem 38:141–155
Pavelka A, Chovancova E, Damborsky J (2009) HotSpot wizard: a web server for identification of hot spots in protein engineering. Nucleic Acids Res 37:W376–W383
Pavlova A, Hwang H, Lundquist K, Balusek C, Gumbart JC (2016) Living on the edge: simulations of bacterial outer-membrane proteins. Biochim Biophys Acta Biomembr 1858:1753–1759
Payandeh Z, Rajabibazl M, Mortazavi Y, Rahimpour A (2017) In silico analysis for determination and validation of human CD20 antigen 3D structure. Int J Pept Res Ther 25:1–13
Ranjbar MM, Nayeb Ali A, Ghorban K, Ghalyanchi Langeroudi A, Dadmanesh M, Amini H-R, Sedighi Moghaddam B (2015) Immnoinformatics: novel view in understanding of immune system function, databases and prediction of immunogenic epitopes. Koomesh 17:18–26
Reguera RM et al (2019) Current and promising novel drug candidates against visceral leishmaniasis. Pure Appl Chem:1–20
Roberts C, McLeod R, Rice D, Ginger M, Chance M, Goad L (2003) Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. Mol Biochem Parasitol 126:129–142
Robinson AJ, Kunji ER (2006) Mitochondrial carriers in the cytoplasmic state have a common substrate binding site. Proc Natl Acad Sci 103:2617–2622
Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5:725–738
Sarkar A, Khan YA, Laranjeira-Silva MF, Andrews NW, Mittra B (2018) Quantification of intracellular growth inside macrophages is a fast and reliable method for assessing the virulence of Leishmania parasites. J Vis Exp 133:e57486
Satheesh KS, Gokulasuriyan RK, Ghosh M (2014) Comparative in-silico genome analysis of Leishmania (Leishmania) donovani: a step towards its species specificity. Meta Gene 2:782–798
Schmidt T, Bergner A, Schwede T (2014) Modelling three-dimensional protein structures for applications in drug design. Drug Discov Today 19:890–897
Sen N, Majumder HK (2008) Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon. Curr Pharm Des 14:839–846
Shaddel M, Oormazdi H, Akhlaghi L, Kazemi B, Bandehpour M (2008) Cloning of Leishmania major P4 gene. Yakhteh Med J 10:201–204
Shaddel M, Sharifi I, Karvar M, Keyhani A, Baziar Z (2018) Cryotherapy of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice: a comparative experimental study. J Vector Borne Dis 55:42–46
Shakya N, Bajpai P, Gupta S (2011) Therapeutic switching in Leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs. J Parasit Dis 35:104–112
Silva LA, Vinaud MC, Castro AM, Cravo PVL, Bezerra JCB (2015) In silico search of energy metabolism inhibitors for alternative leishmaniasis treatments. Biomed Res Int 2015:1–6
Suthar N, Goyal A, Dubey VK (2009) Identification of potential drug targets of Leishmania infantum by in-silico genome analysis. Lett Drug Des Discov 6:620–622
Suzuki E, Tanaka AK, Toledo MS, Levery SB, Straus AH, Takahashi HK (2008) Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies. Biochim Biophys Acta Gen Subj 1780:362–369
Teng Y, Ding Y, Zhang M, Chen X, Wang X, Yu H, Liu C, Lv H, Zhang R (2018) Genome-wide haplotype association study identifies risk genes for non-small cell lung cancer. J Theor Biol 456:84–90
Tian W, Chen C, Lei X, Zhao J, Liang J (2018) CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res 46:W363–W367
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461
Vidhya VM, Dubey VK, Ponnuraj K (2018) Identification of two natural compound inhibitors of Leishmania donovani spermidine synthase (SpdS) through molecular docking and dynamic studies. J Biomol Struct Dyn 36:2678–2693
Viklund H, Elofsson A (2008) OCTOPUS: improving topology prediction by two-track ANN-based preference scores and an extended topological grammar. Bioinformatics 24:1662–1668
Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35:W407–W410
Wu S, Zhang Y (2008) MUSTER: improving protein sequence profile–profile alignments by using multiple sources of structure information. Proteins: Struct, Funct Bioinf 72:547–556
Xun S, Jiang F, Wu Y-D (2015) Significant refinement of protein structure models using a residue-specific force field. J Chem Theory Comput 11:1949–1956